ISTANBUL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS) (the “Company”), a leading Turkish e-commerce platform, will hold its Ordinary General Assembly Meeting of Shareholders (the “General Assembly”) with respect to the financial year 2024, on Monday, September 15, 2025 at 11:00 Istanbul time at the Company's headquarters at Kuştepe Mahallesi, Mecidiyeköy Yolu Caddesi, No:12 Trump Towers Kule:2 Şişli, İstanbul.

Addressing the Demand for Green and Sustainable Transportation Solutions in the Logistics Industry SHANGHAI , Aug. 18, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a provider of AI-powered solutions for next-generation energy grids and intelligent transportation systems, building on its proprietary UOTTATM electric vehicle (EV) battery-swapping technology, today announced that it has signed a Memorandum of Understanding ("MOU") with SAIC HONGYAN Automotive Co., Ltd ("SAIC Hongyan"), a company focused on the development, manufacture, sales and services of heavy trucks, and UNEX EV B.V. ("UNEX EV"), a new energy and technology company, to cooperate on …

BEIJING , Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal Letter"), dated August 18, 2025, from Oceanpine Investment Fund II LP and Oceanpine Capital Inc. (collectively, "Oceanpine Capital") to acquire all of the outstanding ordinary shares, par value US$0.0002 per share, of the Company (the "Ordinary Shares") that are not currently …

NEW YORK , Aug. 18, 2025 /PRNewswire/ -- Payoneer (NASDAQ: PAYO), the global financial technology company powering business growth across borders, today announced a strategic partnership with programmable financial services company Stripe. The collaboration marks an expansion of Payoneer's Online Checkout offering for cross-border merchants looking to sell direct-to-consumer.

Achieves tenfold bandwidth increase, streamlined deployment, and increased network visibility PLANO, Texas , Aug. 18, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced that Vibrant Broadband, part of Meeker Energy, one of the Midwest's first electric cooperatives and a pioneer in rural broadband innovation, has selected its technology for a transformative new middle mile network solution. With proven expertise in rural connectivity, Ribbon empowers providers to deliver critical internet access to underserved communities.

SAN FRANCISCO , Aug. 18, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds Hayward Holdings, Inc. (NYSE: HAYW) investors that the firm is investigating potential legal claims relating to whether the company misled investors about its sales practices and inventory levels. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/haywardupdate.

Known for community, quality and convenience, Supermercado Nuestra Familia will offer full-service Hispanic grocery experience for Golden City shoppers starting in November TOPEKA, Kan. , Aug. 18, 2025 /PRNewswire/ -- Food solutions company SpartanNash® (Nasdaq: SPTN) today announced the expansion of its Supermercado Nuestra Familia® banner, with plans to introduce the Topeka, Kan.

Strategic acquisition expands parts and supplies portfolio for commercial and residential HVAC customers. DALLAS , Aug. 18, 2025 /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient climate control solutions, announced today it has signed a definitive agreement to purchase the HVAC division of NSI Industries from Sentinel Capital Partners for approximately $550 million.

DALLAS , Aug. 18, 2025 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Braemar" or the "Company") announced today that it has successfully refinanced the existing mortgage loan secured by the Four Seasons Resort Scottsdale at Troon North. The previous loan had a balance of $140 million with an interest rate of SOFR + 3.75% and a final maturity in December 2028.

RICHARDSON, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Optex Systems Holdings, Inc. (Nasdaq: OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, is confirmed to present at the 2025 Annual Gateway Conference, which is being held September 3-4 at the Four Seasons Hotel in San Francisco, CA.

~ Strengthens Leadership Incentives and Alignment Around Long-Term Growth Objectives and Disciplined Capital Allocation ~

Kingsway Search Xcelerator's 12th Acquisition Asset-light plumbing services business with recurring revenues and leading market position Purchase price of $5.625 million, plus a potential earn-out of up to $1.125 million, for a total maximum purchase price of $6.75 million Unaudited pro-forma annual revenue of $4.0 million Unaudited pro-forma annual adjusted EBITDA of $0.9 million New credit facility to support growth at Kingsway Skilled Trades CHICAGO, ILLINOIS / ACCESS Newswire / August 18, 2025 / (NYSE:KFS) Kingsway Financial Services Inc. ("Kingsway" or the "Company"), the only publicly-traded US company employing the Search Fund model to acquire and build great businesses, today …

BDX is now attractively valued with a forward PE of 13.7, well below its historical average, making it a compelling value stock. Strong growth in Pharmaceutical Systems and Interventional segments, margin expansion, and a robust innovation pipeline drive business momentum. The upcoming Waters Corp. spin-out will focus BDX on high-growth, recurring revenue segments, enhancing long-term earnings potential.

– Phase 1/2 trial expected to initiate in 2H 2025 in patients with BEST1 inherited retinal disease RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OPGx-BEST1, a gene therapy for the treatment of bestrophin-1 (BEST1)-related IRD.

CHARLOTTE, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (NASDAQ: AMOD) (“Alpha Modus” or the “Company”), a leader in AI-powered retail engagement technologies, today announced that it has entered into an agreement for a transformative capital restructuring that will eliminate approximately $41 million in mezzanine equity, dramatically reduce the Company's stockholders' deficit, retire its last remaining preferred stock, and deliver a cleaner, shareholder-aligned capital structure designed for sustainable growth.

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) between November 7 , 202 4 and Ju ly 8 , 202 5, inclusive. Should You Join This Class Action Lawsuit?

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired publicly traded Sable Offshore Corp. (“Sable Offshore” or the “Company”) (NYSE: SOC) securities between May 19, 2025 and June 3, 2025, inclusive (the “Class Period”), and/or pursuant and/or traceable to the Company's May 21, 2025 secondary public offering. Should You Join This Class Action Lawsuit?

-- Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini, for treatment of adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia -- -- NewAmsterdam entitled to tiered double-digit percentage royalties ranging from the low double-digits to mid-twenties on net sales in the Menarini Territory and up to an additional €833 million upon the achievement of various clinical, regulatory and commercial milestones --

Company expects to complete BLA submission in the fourth quarter of 2025 Company expects to complete BLA submission in the fourth quarter of 2025

-Completes Two Financings, Raising $6.5 Million- -Regains Compliance for Continued Listing on Nasdaq- -Announces Management Changes; Adds Two New Board Members- -Re-Establishes Scientific Advisory Committee- - Reports on New Findings Published in Scientific Journal Nature that Validate LIXTE's Ongoing Clinical Trials with LB-100- -Launches New Pre-Clinical Study- PASADENA, Calif, Aug. 18, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy and immunotherapy, today provided an update on its recent activities. “This has been a transformative period for our company,” …